Endexx® secures third order for non-nicotine vape product HYLA™ worth approximately $1.5M in revenue for the first two fiscal quarters of 2023

Endexx Corporation

HYLA International sales boom

HYLA International sales boom

HYLA International sales boom

$2.3M in HYLA purchase orders generated in West Asia, West Coast America and Dubai in first 55 days since acquisition

CAVE CREEK, AZ, Oct. 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Endexx® Corporation (OTC: EDXC), a provider of innovative, plant-derived and sustainable health and skin care products, today announces that it has placed three significant major orders for its newly acquired, non-nicotine plant based vape product, HYLA™. These orders drive combined revenue of $2.3 million in the first two fiscal quarters.

The orders came from distributors in the western region of the US, a Central Asian nation, and Dubai in the UAE. The first two will generate combined revenues of approximately $827,000, while the Dubai order will generate approximately another $1,500,000 in revenue during Endexx’s first two fiscal quarters. The order in Dubai is six months from now with potential for accelerated growth.

Todd Davis, CEO of Endexx, stated: “HYLA has been an important addition to our product offering while continuing our mission to bring innovative, plant-based consumer products to consumers. Importantly, this first wave of orders puts us on track to recoup the investment made to acquire HYLA in the second quarter of this year and significantly increase our overall revenues.”

Nick Mehdi, CEO of Hyla Division, stated, “The market in Dubai, UAE is highly influential in identifying trends, consumer behavior and market expansion in the Middle East.” Mr Mehdi added, “HYLA products represent the best alternative to replace nicotine based vape products both internationally and here in the US.” Mehdi concluded, “The transaction in Dubai opens up the entire market in the region and we expect significant growth in distribution.”

“Combined with both our CBD pain and skin care products for men and non-CBD skin care line, we believe we are creating an important niche franchise that will appeal to an increasingly wide audience worldwide. Our distribution for our Blesswell™ line includes some of the largest retailers in the country, including Target, CVS and Amazon, and we believe that the acquisition of HYLA – in addition to generating revenue from direct sales – will also give us additional international access will offer. We look forward to continuing to update shareholders on our progress,” concludes Mr. Davis.

About Endexx Corporation

Endexx Corporation develops and distributes all-natural, plant-derived topical skin care products. The products range from balms, creams, lotions, butters, masks, scrubs and oils, all with the shared goal of healthy skin and care. The science behind these products includes a decade of field clinical research and laboratory work to provide functional formulations with ingredients for optimal absorption and support of skin health. www.endexx.com www.tryHyla.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

We caution that any forward-looking statements (as defined in the US Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management or our spokespersons involve risks and uncertainties and are subject to change. based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future results of operations, the implementation and impact of our strategic plans, and our ability to achieve environmental, social and governance goals. Words like “estimate,” “dedicate,” “strive,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend” ‘. “Potential” and similar expressions can identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied by forward-looking statements:

Except as required by law, we assume no obligation and do not intend to release any updates or other revisions to the forward-looking statements contained in this press release to reflect circumstances that exist after the date of this press release or to the occurrence of future events, even if experience or future events indicate that the expected results expressed or implied by those forward-looking statements will not be achieved. More information about potential factors that could affect our results is included in “Risk Factors” in our annual report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2022.

For more information, please address:
Endexx Corporation
[email protected]
480-595-6900

investors:
Scott Arnold
KERN IR
[email protected]

Media:
Jules Abraham
KERN IR
Email: [email protected]
Phone: 917-885-7378

Appendix

Endexx® secures third order for non-nicotine vape product HYLA™ worth approximately $1.5M in revenue for the first two fiscal quarters of 2023

Leave a Reply

Your email address will not be published.

Scroll to top